Quantitative Reverse Transcription-Polymerase Chain Reaction Measurement of HASH1 (ASCL1), a Marker for Small Cell Lung Carcinomas with Neuroendocrine Features by WESTERMAN, Bart A, NEIJENHUIS, Sari, POUTSMA, Ankie, STEENBERGEN, Renske D. M, BREUER, Roderick H. J, EGGING, Monique, VAN WIJK, Inge J, OUDEJANS, Cees B. M

Get full text

Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ) by Snijders, Peter J.F., Breuer, Roderick H.J., Sutedja, Thomas G., Egging, Monique, Voorhorst, Feja J., Steenbergen, Renske D.M., van der Linden, Hans C., Risse, Elle K., Berkhof, Johannes, de Vries, Elisabeth G.E., van der Zee, Ate G.J., Postmus, Pieter E., Meijer, Chris J.L.M., Smit, Egbert F.

Get full text

The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers by van der Lee, Miranda M C, Groothuis, Patrick G, Ubink, Ruud, van der Vleuten, Monique A J, van Achterberg, Tanja A, Loosveld, Eline M, Damming, Désirée, Jacobs, Daniëlle C H, Rouwette, Myrthe, Egging, David F, van den Dobbelsteen, Diels, Beusker, Patrick H, Goedings, Peter, Verheijden, Gijs F M, Lemmens, Jacques M, Timmers, Marco, Dokter, Wim H A

Get full text

Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platform by Dokter, Wim, Ubink, Ruud, van der Lee, Miranda, van der Vleuten, Monique, van Achterberg, Tanja, Jacobs, Danielle, Loosveld, Eline, van den Dobbelsteen, Diels, Egging, David, Mattaar, Ellen, Groothuis, Patrick, Beusker, Patrick, Coumans, Ruud, Elgersma, Ronald, Menge, Wiro, Joosten, John, Spijker, Henri, Huijbregts, Tijl, de Groot, Vincent, Eppink, Michel, de Roo, Guy, Verheijden, Gijs, Timmers, Marco

Get full text

Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice by Ubink, Ruud, Dirksen, Eef H C, Rouwette, Myrthe, Bos, Ebo S, Janssen, Ingrid, Egging, David F, Loosveld, Eline M, van Achterberg, Tanja A, Berentsen, Kim, van der Lee, Miranda M C, Bichat, Francis, Raguin, Olivier, van der Vleuten, Monique A J, Groothuis, Patrick G, Dokter, Wim H A

Get full text

Abstract 5360: The preclinical profile of the duocarmycin-based HER2-targeting ADC SYD985 predicts for clinical benefit in low HER2-expressing breast cancers by Dokter, Willem, van der Lee, Miranda, Groothuis, Patrick, Ubink, Ruud, van der Vleuten, Monique, van Achterberg, Tanja, Loosveld, Eline, Damming, Desirée, Rouwette, Myrthe, Egging, David, van den Dobbelsteen, Diels, Beusker, Patrick, goedings, peter, Verheijden, Gijs, Lemmens, Jacques, Timmers, Marco

Get full text

Abstract 2651: Impressive efficacy and safety profile of a novel generation duocarmycin-based HER2-targeting ADC by Dokter, Willem, Ubink, Ruud, Lee, Miranda van der, Vleuten, Monique van der, Achterberg, Tanja van, Jacobs, Daniëlle, Dobbelsteen, Diels van den, Egging, David, Mattaar, Ellen, Groothuis, Patrick, Beusker, Patrick, Coumans, Ruud, Elgersma, Ronald, Eppink, Michel, Roo, Guy de, Verheijden, Gijs, Timmers, Marco

Get full text